Comparison of Ceftibuten vs. Amoxicillin/Clavulanic Acid as Antibiotic Prophylaxis in Cholecystectomy and/or Biliary Tract Surgery

Journal of Gastrointestinal Surgery

Volumn 4, Issue 6, 2000, Pages 606-610

  Orozco, Hector ^a   Sifuentes Osornio, Jose ^a   Chan, Carlos ^a   Medina Franco, Heriberto ^a,b   Vargas Vorackova, Florencia ^c   Prado, Eduardo ^a   Arch, Jorge ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c NONE

Author keywords

Biliary surgery; Ceftibuten; Cephalosporins; Prophylaxis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFTIBUTEN; CEPHALOSPORIN DERIVATIVE;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BILIARY TRACT DISEASE; CHOLECYSTECTOMY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; FOLLOW UP; GALLBLADDER DISEASE; HUMAN; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; MALE; METHODOLOGY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PROBABILITY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SURGICAL INFECTION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; AGED; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTIBIOTIC PROPHYLAXIS; BILIARY TRACT DISEASES; CEPHALOSPORINS; CHOLECYSTECTOMY; COST-BENEFIT ANALYSIS; FEMALE; FOLLOW-UP STUDIES; GALLBLADDER DISEASES; HUMANS; INCIDENCE; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROBABILITY; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 0034329116     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(00)80109-2     Document Type: Article

References (26)

1. Bordon DW. Principles of antimicrobial prophylaxis. World J Surg 1982;6:262-267.
2. Plat R. Antibiotic prophylaxis in surgery. Rev Infect Dis 1984;6:1880-1886.
3. Orozco H, Sifuentes J, Prado E, Takahashi T, López-Graniel CM, Anaya F., Canto J. [Comparison of two antimicrobial prophylaxis regimens in biliary tract surgery; A randomized controlled clinical trial]. Rev Invest Clin 1993;45:565-569 (in Spanish).
4. Wise R. The pharmacokinetics of the oral cephalosporins - A review. J Amtimicrob Chemother 1990;26(Suppl E):13-20.
5. Fassbender M, Lode H, Schaberg T, Borner K, Koeppe P. Pharmacokinetics of new oral cephalosporins, including a new carbacephem. Clin Infect Dis 1993;16:646-653.
6. Lode H, Fassbender M, Schaberg T, Borner K, Koeppe P. Comparative pharmacokinetics of the new oral cephalosporins. Drugs 1994;47(Suppl 3):10-19.
7. Kearns GL, Young RA, Ceftibuten pharmacokinetics and pharmacodynamics. Focus on pediatric use. Clin Pharmacokinet 1994;26:169-189.
8. Rosenfeld RM, Doyle WJ, Swarts JD, SerokyJ, Greene I. Efficacy of ceftibuten for acute otitis media caused by Haemophilus influenzae: An animal study. Ann Otol Rhinol Laryngol 1993;102:222-226.
9. Chin NX, Gu JW, Nen HC. Antimicrobial effects of the combination of ceftibuten and an orally absorbed penem SCH 29482. Diagn Microbiol Infect Dis 1991;14:79-83.
10. Barr WH, Lin CC, Radwanski E, Lim J, Symchowicz, S, Affrime M. The pharmacokinetics of ceftibuten in humans. Diagn Microbiol Infect Dis 1991;14:93-100.
11. Baurnfeind A, Jungwrith R. Antibacterial activity cefpodoxime in comparison with cefixime, cefnidir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefradroxil. Infection 1991;19:353-362.
12. Jones RN. Antimicrobial activity and spectrum of ceftibuten (7432-S, SHC 39720). A review of United States and Canada results. Diagn Microbiol Infect Dis 1991;14:37-43.
13. Debbia EA, Pesce A, Chiesa M, Ricotta N, Schito GC, Microbiologic profile of ceftibuten, a new oral cephalosporin. Drugs Exp Clin Res 1992;18:129-139.
14. Soussy CJ, Meyran M, Chanal M, Reverdy ME, Khzis MD, Derlot E. In vitro antibacterial activity of a new oral cephalosporin, ceftibuten. Results of a multicentric study. Pathol Biol 1991;39:396-402.
15. Prado D, Lopez E, Liu H, Devoto S, Woloj M, Contrini M, Murray BE, Gomez H, Cleary T. Ceftibuten and trimethoprim/sulfamethoxazole for treatment of Shigella and enteroinvasive Escherichia coli disease. Pediarr Infect Dis J 1992;11:644-647.
16. Gorbach SL, Condon RE, Conte JE Jr, Kaiser AB, Ledger WJ, Lee-Nichols R. Evaluation of new anti-infective drugs for surgical prophylaxis. Infectious Disease Society of America and the Fond and Drug Administration. Clin Infect Dis 1992;15(S1):313-338.
17. Zar JH. Biostatistical Analysis, 2nd ed. New York: Prentice Hall, 1984.
18. Chetlin SH, Elliot DW Preoperative antibiotics in biliary surgery. Arch Surg 1973;107:319-323.
19. Keighley MRB, Baddeley RM, Burdon DW. A controlled trial of parenteral prophylactic therapy in biliary surgery. Br J Surg 1975;62:275-279.
20. Griffiths DA, Shorey BA, Simpson RA. Single-dose preoperative antibiotic prophylaxis in gastrointestinal surgery. Lancet 1976;2:325-328.
21. Waddell TK, Rotstein OD, Antimicrobial prophylaxis in surgery. Committee on antimicrobial agents, Canadian Infectious Disease Society, Can Med Assoc J 1995;152:1381-1382.
22. McArdle CS, Morran CG, Pettit L, Gemmell CG, Sleigh JD, Tillotson GS. Value of oral antibiotic prophylaxis in colorectal surgery. Br J Surg 1995;82:1046-1048.
23. Nungu KS, Olerud C, RehnbergL, Larsson S, Nordell P, Al-Ivin I, Bengtsson S, Wallinder L, Hedin G. Prophylaxis with oral cefadroxil versus intravenous cefuroxime in trochanteric fracture surgery. A clinical multicentre study. Arch Orthop Trauma Surg 1995;114:303-307.
24. McArdle CS, Morran CG, Anderson JR, Pettit L, Gemmell CG, Sleigh JD, Tillotson GS. Oral ciprcifloxacin as prophylaxis in gastroduodenal surgery. J Hosp Infect 1995;30:211-216.
25. Risberg B, Drott C, Dalman P, Holm J, Ivarsson L, Jivegard L, Karlstrom L, Oden A, Pedersen P, Rahm V, et al. Oral ciprofloxacin versus intravenous cefuroxime as prophylaxis against postoperative infection in vascular surgery: Randomized double-blind, prospective multicentre study. Eur J Vasc Endovasc Surg 1995;10:346-351.
26. Botto H, Butreau-Lamaire M, Levy S, Deval C. [Oral ofloxacin versus intramuscular ceftriaxone in antibiotic prophylaxis in transurcthral prostate resection]. Prog Urol 1993; 3:569-575 (in French).